AmpliPhi Biosciences Competitors and Similar CompaniesClear all
AmpliPhi Biosciences's competitors and similar companies include Axsome Therapeutics, WuXi AppTec, Abliva and Prevail Therapeutics.
 AmpliPhi Biosciences AmpliPhi Biosciences is a biotechnology company focused on developing novel bacteriophage-based therapeutics. |  Axsome Therapeutics Axsome Therapeutics is a clinical-stage biopharmaceutical company that develops therapies for the management of central nervous system disorders. |  WuXi AppTec WuXi AppTec (无锡药明康德新药开发股份有限公司, formerly known as WuXi PharmaTech) is a company that provides integrated research, development, and manufacturing solutions for drug discovery and production. |  Abliva Abliva is a biotech company that discovers and develops medicines for the treatment of mitochondrial disease. |  Prevail Therapeutics Prevail Therapeutics is a biotech company that is developing therapeutics for neurodegenerative disorders, such as Parkinson's disease. | |
Founding Date | Founding Date 1989 | Founding Date 2012 | Founding Date 2000 | Founding Date 2000 | Founding Date 2017 |
Type | Type Private | Type Public | Type Public | Type Subsidiary | Type Public |
Tags | |||||
Locations | Locations San Diego, US HQ Brookvale, AU Ljubljana, SI Richmond, US | Locations New York, US HQ New York, US | Locations Shanghai, CN HQ Beijing, CN Changzhou, CN Chengdu, CN Nanjing, CN Nantong, CN Shanghai, CN see more | Locations Lund, SE HQ | Locations New York, US HQ |
Employees | Employees 303% decrease | Employees 4111% increase | Employees 39,414 | Employees 950% increase | Employees 489% increase |
Valuation ($) | Valuation ($) N/A | Valuation ($) 4.3 b | Valuation ($) 20.7 b | Valuation ($) N/A | Valuation ($) 787.7 m |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $638.5m (FY, 2025) | Revenue (est.) ¥43.1b (FY, 2025) | Revenue (est.) N/A | Revenue (est.) N/A |
Cost of goods | Cost of goods N/A | Cost of goods N/A | Cost of goods ¥23.8b (FY, 2025) | Cost of goods N/A | Cost of goods N/A |
Gross profit | Gross profit N/A | Gross profit N/A | Gross profit ¥21.3b (FY, 2025) | Gross profit kr497k (FY, 2024) | Gross profit N/A |
Net income | Net income ($23.2m) (FY, 2021) | Net income ($183.2m) (FY, 2025) | Net income ¥19.3b (FY, 2025) | Net income (kr90m) (FY, 2024) | Net income ($63.2m) (FY, 2019) |
Funding | |||||
Total funding raised | Total funding raised $ 44m | Total funding raised $ 7m | Total funding raised $ 902.6m | Total funding raised $ 10.8m | Total funding raised $ 125m |
For sources of this data, please see the company profile
View Company Profiles
Axsome Therapeutics
HQ
New York, US
Employees
41↑ 11% increase
Axsome Therapeutics is a clinical-stage biopharmaceutical company that develops therapies for the management of central nervous system disorders.
View companyWuXi AppTec
HQ
Shanghai, CN
Employees
39,414
WuXi AppTec (无锡药明康德新药开发股份有限公司, formerly known as WuXi PharmaTech) is a company that provides integrated research, development, and manufacturing solutions for drug discovery and production.
View companyAbliva
HQ
Lund, SE
Abliva is a biotech company that discovers and develops medicines for the treatment of mitochondrial disease.
View companyPrevail Therapeutics
HQ
New York, US
Employees
48↑ 9% increase
Prevail Therapeutics is a biotech company that is developing therapeutics for neurodegenerative disorders, such as Parkinson's disease.
View company